BEAM THERAPEUTICS INC

Beam Therapeutics insider trading insights: CEO Evans’ disciplined buys and sells reveal liquidity strategy and potential bullish signals amid valuation challenges.

Beam Therapeutics President moves 123k shares into a family trust—no cash sale, minimal market impact, but key signal for investors watching insider strategy.